DB1976 dihydrochloride

• CAT Number: I016832
• CAS Number: 2369663-93-2
• Molecular Formula: C₂₀H₁₈Cl₂N₈Se
• Molecular Weight: 520.28
• Purity: ≥95%
• Target: Apoptosis
• IUPAC Name: 2-[5-(6-carbamimidoyl-1H-benzimidazol-2-yl)selenophen-2-yl]-3H-benzimidazole-5-carboximidamide;dihydrochloride
• InChI: InChI=1S/C20H16N8Se.2ClH/c21-17(22)9-1-3-11-13(7-9)27-19(25-11)15-5-6-16(29-15)20-26-12-4-2-10(18(23)24)8-14(12)28-20;;/h1-8H,(H3,21,22)(H3,23,24)(H,25,27)(H,26,28);2*1H
• InChIKey: ZXDJCXGSFWTRMS-UHFFFAOYSA-N
• SMILES: C1=CC2=C(C=C1C(=N)N)NC(=N2)C3=CC=C([Se]3)C4=NC5=C(N4)C=C(C=C5)C(=N)N.Cl.Cl

DB1976 Dihydrochloride(CAT: I016832) is a potent and selective small-molecule inhibitor of bromodomain and extra-terminal (BET) proteins, particularly targeting BRD4. BET proteins are key regulators of transcription and play critical roles in cancer progression, inflammation, and epigenetic regulation. DB1976 Dihydrochloride is widely used in research to explore the mechanisms of transcriptional control, chromatin remodeling, and the development of BET-targeted therapies. Its high purity and stability make it ideal for in vitro and in vivo studies, supporting advanced research in oncology, immunology, and epigenetics. This compound aids in the discovery of novel therapeutic approaches for BET-related diseases.